Stock AVEXIS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

AveXis Inc Stock

Equities

US05366U1007

Biotechnology & Medical Research

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Chart AveXis Inc

Dynamic Chart

Latest news about AveXis Inc

Novartis : top lawyer exits over Trump attorney deal 'mistake' RE
Novartis : top lawyer exits over Trump attorney deal 'mistake' RE
Novartis : CEO feels heat on U.S. generics, Cosentyx drop RE
GlaxoSmithKline : GSK slims portfolio with sale of rare disease gene therapy drugs RE
GlaxoSmithKline : UK gene therapy firm Orchard plans stock offer after GSK deal RE
Takeda sounds out banks for loans as it moves towards Shire bid: sources RE
Takeda sounds out banks for loans as it moves towards Shire bid: sources RE
Takeda Pharmaceutical : sounds out banks for loans as it moves towards Shire bid - sources RE
Wall Street rises but pares gains late after report of FBI raid RE
Takeda Pharmaceutical : Novartis bets big on gene therapy with $8.7 billion AveXis deal RE
Takeda Pharmaceutical : Novartis bets big on gene therapy with $8.7 billion AveXis deal RE
Takeda Pharmaceutical : Novartis bets big on gene therapy with $8.7 billion AveXis deal RE
European shares rise as trade optimism spreads RE
AveXis : Novartis AG to buy AveXis Inc for $8.7 billion RE
More news

Press releases AveXis Inc

AveXis Reports First Quarter 2018 Financial and Operating Results GL
AveXis Provides Update on Proposed Acquisition by Novartis AG GL
AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3 GL
AveXis : RM LAW Announces Investigation of AveXis, Inc. PR
AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of Neurology GL
More press releases

News in other languages on AveXis Inc

Les valeurs à suivre aujourd'hui à Wall Street - Mercredi 18 avril 2018
AVEXIS : l'offre de NOVARTIS s'ouvre aujourd'hui jusqu'au 14 mai
REPETE : Les grandes biotech ont les moyens de redorer leur blason à Wall Street - Plus USA
REPETE : Les grandes biotech ont les moyens de redorer leur blason à Wall Street -- Plus USA
Alexion Pharmaceuticals : acquiert la biotech suédoise Wilson Therapeutics
More news

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+10.10% 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.91% 107B
BIONTECH SE Stock BioNTech SE
-5.28% 22.22B
ARGENX SE Stock argenx SE
-0.67% 21.28B
GENMAB A/S Stock Genmab A/S
-4.64% 18.8B
BEIGENE, LTD. Stock BeiGene, Ltd.
-6.58% 17.51B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.36% 17.17B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.84% 14.14B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+34.95% 12.2B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW